Effects and mechanism of Ginseng Yixin granules (QSYXG) for heart failure with preserved ejection fraction based on the network pharmacology and molecular docking strategy
10.12092/j.issn.1009-2501.2023.10.001
- Author:
Yulin CHEN
1
;
Hugang JIANG
1
;
Xinqiang WANG
1
;
Kai LIU
1
;
Yingdong LI
1
;
Xinke ZHAO
1
;
Xinke ZHAO
2
;
Hugang JIANG
3
;
Xinqiang WANG
3
;
Kai LIU
3
;
Yingdong LI
3
;
Xinke ZHAO
3
;
Tao AN
4
Author Information
1. College of Integrated Traditional Chinese and Western Medicine, Gansu University of Traditional Chinese Medicine
2. The Third Affiliated Hospital of Gansu University of Traditional Chinese Medicine
3. Key Laboratory of Prevention and Treatment of Chronic Diseases
4. Heart Failure Center, Fuwai Hospital, National Cardiovascular Center of Chinese Academy of Medical Sciences, Peking Union Medical College
- Publication Type:Journal Article
- Keywords:
Ginseng Yixin granules;
heart failure with preserved ejection fraction;
mechanism of action;
molecular docking;
network pharmacology;
signaling pathways
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2023;28(10):1081-1092
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To study the mechanism of Ginseng Yixin granules (QSYXG) in treating ejection fraction preserved heart failure (HFpEF) based on network pharmacology. METHODS: Effective chemical composition information of QSYXG particles was collected through TCMSP database; DisGeNET, GeneCards, OMIM database for obtaining HFpEF related targets; Metascape GO and KEGG enrichment analysis of the intersection targets of HFpEF; STRING Construction and analysis of the database PPI network; Cytoscape3.7.2 Software construction network diagram; Docking of the major active components to the core target with the AutoDock Vina software molecules, the results were visualized and analyzed with pymol. RESULTS: A total of 66 components and corresponding targets were obtained, HFpEF corresponds to 1 931 targets, The intersection of 127 targets, the main active ingredients are quercetin, kaempferol, β-sitosterol, etc.; TNF, AKT1, IL-6, P53 and JUN as the core targets, Good docking of the key components with the core targets; Mainly involving the positive regulation of gene expression, signal transduction, negative regulation of apoptotic process, positive regulation of cell proliferation and senescence, hypoxia response, negative regulation of gene expression, inflammatory response and so on, PI3K-Akt, AGE-RAG, MAPK, TNF, IL-17, and HIF-1 are the main associated signaling pathways. CONCLUSION: QSYXG may treat HFpEF by activating targets of TNF, AKT1, IL-6, P53, JUN, and regulating apoptotic process, cell proliferation, hypoxia response, and inflammatory response.
